Mobile Menu

Search Results

Search results for: Health

SARS-CoV-2 assay cleared for clinical use in Singapore

Singapore’s Health Sciences Authority has authorised clinical use of a new test for SARS-CoV-2 according to the Agency for Science, Technology, and Research (A*STAR).

Genetic sequencing of novel coronavirus indicates “undetected spread” in the US

Recent analysis of the genetic sequence of the coronavirus has indicated that the infection may have spread further than we realised. 

Initiative to improve diagnosis of childhood viral lymphomas using liquid biopsy launched

Researchers hope that the effort will be able to validate liquid biopsy (LB) diagnostic methods for childhood lymphomas that are endemic in the region

First gene catalogue of human vaginal microbiome created

The catalogue, Human Vaginal Non-Redundant gene catalogue (VIRGO), has been released publicly and can be used to facilitate an in-depth understanding of how the vaginal micro-organisms affect women’s health

Enabling Precision medicine for everyone: New pharmacogenomics solution launched in the US

The PGx program is an industry-first solution that will protect patients from being prescribed ineffective or harmful drugs.

“We need to have resilience and tolerance for failure” – Interview with Guillermo Del Angel, Alexion Pharmaceuticals

FLG: Can you introduce yourself and your work? I’m Guillermo del Angel and I’m the Senior Director for Data Science […]

New diagnostic for Coronavirus receives CE mark

Yesterday, a test developed by Co-diagnostics for the detection of SARS-CoV-2, received CE marking as the virus nears “pandemic” status. CE-IVD marking indicates that the IVD conforms with relevant EU directives regarding the health and safety of the product.

Alzheimer’s disease genetic research consortium launched in New York

The State University of New York (SUNY) is running the program with $20 million funding from the Empire State Development’s […]

FDA releases list of evidence-based pharmacogenetic variants

Pharmacogenetics (PGx) is the study of how an individual’s genetic makeup affects their drug response and metabolism. An understanding of PGx could help clinicians make prescribing decisions and has the potential to be implemented in routine care worldwide. PGx has understandably been gaining traction and support, with pharmacogenomic elements being implemented into many international Genomic studies.

WGS – The future of consumer genomics

With the falling cost of genome sequencing, it comes as no surprise that there is a growing interest in expanding the availability and accessibility of genomics via consumer testing. Now, Nebula Genomics has entered the market by launching a comprehensive at-home test that analyses the whole genome for just $299.